|
|
Hang Shi, Maia V. Kokoeva, Karen Inouye, Iphigenia Tzameli, Huali Yin, Jeffrey S. Flier
J Clin Invest. 2006;
116(11):3015
doi:10.1172/JCI28898
Abstract |
Full text
| PDF

T
LR4 is the receptor for LPS and plays a critical role in innate immunity. Stimulation of TLR4 activates proinflammatory pathways and induces cytokine expression in a variety of cell types. Inflammatory pathways are activated in tissues of obese animals and humans and play an important role in obesity-associated insulin resistance. Here we show that nutritional fatty acids, whose circulating levels are often increased in obesity, activate TLR4 signaling in adipocytes and macrophages and that the capacity of fatty acids to induce inflammatory signaling in adipose cells or tissue and macrophages is blunted in the absence of TLR4. Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism. Finally, female C57BL/6 mice lacking TLR4 have increased obesity but are partially protected against high fat diet–induced insulin resistance, possibly due to reduced inflammatory gene expression in liver and fat. Taken together, these data suggest that TLR4 is a molecular link among nutrition, lipids, and inflammation and that the innate immune system participates in the regulation of energy balance and insulin resistance in response to changes in the nutritional environment.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(117)
| Title and authors |
Publication |
Year |
Toll-like receptors and diabetes: a therapeutic perspective
Mohan R. Dasu, Sandra Ramirez, Roslyn R. Isseroff
|
Clin. Sci.
|
2012 |
The diversity of sex steroid action: regulation of metabolism by estrogen signaling
M. H. Faulds, C. Zhao, K. Dahlman-Wright, J.-A. Gustafsson
|
Journal of Endocrinology
|
2012 |
The Inflammasome Puts Obesity in the Danger Zone
Rinke Stienstra, Cees J. Tack, Thirumala-Devi Kanneganti, Leo A.B. Joosten, Mihai G. Netea
|
Cell Metabolism
|
2012 |
Foods for the prevention of diabetes: how do they work?
Theodoros Thomas, Andreas F. H. Pfeiffer
|
Diabetes Metab. Res. Rev.
|
2012 |
Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice
Seung-Jin Kim, Youngshim Choi, Youn-Hee Choi, Taesun Park
|
The Journal of Nutritional Biochemistry
|
2012 |
The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance
Shawn Winer, Daniel A Winer
|
Immunol Cell Biol
|
2012 |
Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater Adiposity
Karen K. Ryan, Stephen C. Woods, Randy J. Seeley
|
Cell Metabolism
|
2012 |
Inflammation and type 2 diabetes
M.C. Calle, M.L. Fernandez
|
Diabetes & Metabolism
|
2012 |
Bioactive compounds with effects on inflammation markers in humans
Flávia Troncon Rosa, M. Ángeles Zulet, Julio Sérgio Marchini, J. Alfredo Martínez
|
Int J Food Sci Nutr
|
2012 |
Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis
Nina L. Cluny, RayleneA. Reimer, Keith A. Sharkey
|
Brain Behavior Immunity
|
2012 |
|